JP3660833B2 - Blood circulation promoter - Google Patents

Blood circulation promoter Download PDF

Info

Publication number
JP3660833B2
JP3660833B2 JP22232299A JP22232299A JP3660833B2 JP 3660833 B2 JP3660833 B2 JP 3660833B2 JP 22232299 A JP22232299 A JP 22232299A JP 22232299 A JP22232299 A JP 22232299A JP 3660833 B2 JP3660833 B2 JP 3660833B2
Authority
JP
Japan
Prior art keywords
blood circulation
extract
skin
phase
circulation promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP22232299A
Other languages
Japanese (ja)
Other versions
JP2001048740A (en
Inventor
信彦 落合
勇二 舛田
元次 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP22232299A priority Critical patent/JP3660833B2/en
Publication of JP2001048740A publication Critical patent/JP2001048740A/en
Application granted granted Critical
Publication of JP3660833B2 publication Critical patent/JP3660833B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、植物抽出物を有効成分とする、皮膚の血行を促進する作用を有する血行促進剤に関する発明である。
【0002】
【従来の技術】
皮膚の血行を促進することは、身体の健康と美容にとって大変有益なことである。すなわち、皮膚の血行を促進することにより、身体の新陳代謝が促進され、身体全体にとって大変有益である。また、美容上も、血色がよくなり、肌のくすみを防止することも可能であるばかりか、皮膚における新陳代謝の向上により、皮膚組織に栄養と水分が十分に供給されることで、うるおいのある若々しい肌を維持することも可能になり、これにより皮膚の老化を防止し得る等、その効用は計り知れない。
【0003】
よって、皮膚の血行を促進し得る成分を見い出し、これを、皮膚外用剤や浴用剤として用い得る血行促進剤の有効成分とする試みがなされている。現在までに見いだされている、皮膚の血行を促進し得る成分としては、例えば、カプサイシン、ビタミンE類、ヨモギ抽出物等を挙げることができる。
【0004】
【発明が解決しようとする課題】
本発明が解決すべき課題は、外用に適した血行促進成分をさらに見い出し、これにより、皮膚の血行を促進して、身体の健康と美容に貢献し得る新たな手段を提供することにある。
【0005】
【課題を解決するための手段】
本発明者は、鋭意検討の結果、バラ科のキイチゴ属(Rubus L.)に属する植物の抽出物に、優れた皮膚の血行を促進する作用が認められることを見出し、これを血行促進剤の有効成分として用いることで、上記の課題を解決し得ることを見出した。
【0006】
すなわち、本発明者は、本願において、バラ科(Rosaceae)キイチゴ属(RubusL.)に属する植物の抽出物(以下、この抽出物を、キイチゴ抽出物ともいう)を有効成分とする血行促進剤(以下、本発明血行促進剤ともいう)を提供する。この本発明血行促進剤は、例えば、皮膚外用剤として用いることで、その特徴を存分に発揮することができる。
【0007】
【発明の実施の形態】
以下、本発明の実施の形態について説明する。
A.本発明血行促進剤の有効成分
本発明血行促進剤の有効成分であるキイチゴ抽出物の原材料である、キイチゴ属(Rubus L.)に属する植物は、上述のように、バラ科(Rosaceae)に属しており、一般的には、ブラックベリー(Blackberry)やラズベリー(Raspberry) として知られており、その果実は食用として広く用いられている。
【0008】
本発明において、上記のキイチゴ属に属する植物は、特に限定されず、キイチゴ属の既存種や様々な交配種から1種又は2種以上を自由に選択することができる。
【0009】
キイチゴ属に属する植物の既存種としては、Rubus(以下、R.とも記載する)allegheniensis Port.、チシマイチゴ(R.arcticus L. )、R.argutus Link、フユイチゴ(R.buergeri Miq.) 、R.caesius L.、R.canadensis L. 、ホロムイイチゴ(R.chamaemorus L.)、ゴショイチゴ(R.chingii Hu)、R.commersonii 、クマイチゴ(R.crataegifolious Bunge) 、オニイチゴ(R.ellipticus Sm.)、R.frondosus Bigel.、セイヨウヤブイチゴ(R.fruticosus L.) 、ヒメフユイチゴ(R.hayata-koidzumii Naruhashi)、クサイチゴ(R.hirsutus Thunb.) 、ヨーロッパキイチゴ(エゾキイチゴ:R.idaeus L.)、バライチゴ(R.illecebrosus Focke)、R.laciniatus Willd. 、R.×loganobaccus Bailey 、ニガイチゴ(R.microphyllus L.f.) 、ナンヨウキイチゴ(R.moluccanus L.) 、R.×neglectus Peck. 、R.niveus Thunb. 、クロミキイチゴ(R.occidentalis L.) 、モミジイチゴ(R.palmatus Thunb.) 、ナワシロイチゴ(R.parvifolius L.)、コガネイチゴ(R.pedatus J.E.Smith) 、エビガライチゴ(R.phoenicolasius)、R.proceus P.J.Muell.、バラバキイチゴ(R.rosaefolius Smith) 、トキンイバラ(Var.coronarius Smith)、ホウロクイチゴ(R.sieboldii Bl.) 、R.spectabilis Pursh.、カジイチゴ(R.trifidus Thunb.) 、R.ursinus Cham.et Schlecht. 、ベニバナイチゴ(R.vernus Focke)等を挙げることができるが、これらに限定されるものではない。
【0010】
これらのキイチゴ属に属する植物のうち、ヨーロッパキイチゴ(エゾキイチゴ:R.idaeus L.) 、その亜種(例えば、subsp.vulgatus、subsp.strigosus 、subsp.melanolasia Focke 、subsp.sachalinensis Leveille、subsp.sibiricus 等) 及び近縁種(例えば、ホロムイイチゴ、R.xanthocarpus、チシマイチゴ、ナワシロイチゴ、クロミキイチゴ、R.ursinus 、モミジイチゴ等) は、本発明において好ましく用い得る。本発明において、「ヨーロッパキイチゴ」とは、上記の亜種と近縁種も含むものとする。
【0011】
キイチゴ抽出物の原材料となり得るキイチゴ属に属する植物は、生のままでも乾燥したものでも使用することが可能であり、使用部位は、植物体全体、すなわち、花、葉、茎又は果実を広く用いることができるが、特に果実を選択することが好ましい。
【0012】
キイチゴ抽出物は、その果実等に由来する果汁として用いることも、上記のキイチゴ属に属する植物体から、抽出工程(例えば、抽出溶媒とともに浸漬または加熱還流した後、濾過し、濃縮する)を経る常法により得られる抽出物を用いることも可能である。。また、一旦、抽出溶媒で抽出した得た抽出液をそのまま、あるいは濃縮して得たエキスを、吸着法で処理したもの〔例えば、イオン交換樹脂を用いて不純物を除去したものや、ポーラスポリマー(例えばアンバーライトXAD−2)のカラムで吸着させた後、メタノールまたはエタノールで溶出し、濃縮したもの等〕や、分配法、例えば、水/酢酸エチルで抽出した抽出物等も本発明において用いることができる。上記の抽出溶媒としては、通常抽出に用いられる溶媒であれば任意に用いることが可能であり、例えば、水、アルコール類(メタノール、エタノール、プロピレングリコール、1,3−ブチレングリコール、グリセリン等)、含水アルコール類、クロロホルム、ジクロルエタン、四塩化炭素、アセトン、酢酸エチル、ヘキサン等を、それぞれ単独あるいは組み合わせて用いることができる。
【0013】
また、キイチゴ抽出物の市販品を、本発明において用いることも可能である〔例えば、キイチゴエキスとして「キイチゴ抽出液BG」(丸善社製)、「ダーモフルーツラズベリー」(香栄興業社製)、さらにキイチゴ果汁として「ダーモフルーツラズベリーB」(香栄興業社製)等〕。
【0014】
なお、本発明におけるキイチゴ抽出物には、上述したような文字通りの抽出物の他に、キイチゴ属に属する植物の、生の又は乾燥した植物体も含まれる。
【0015】
キイチゴ属に属する植物は、その薬効成分として、リンゴ酸、クエン酸、フラボノイド、ビタミンC、ビタミンPを主とする各種のビタミンや糖類等を含むことから、皮膚炎(湿疹、アクネ)、消炎剤、下痢止めなどへの利用が知られている。
【0016】
また、キイチゴ抽出物には、発毛、育毛効果(特開平3−188014号公報)、ニキビ改善効果(特開平3−188015号公報)、メラニン生成抑制効果(特開平7−25741号公報)、ヒアルロニダーゼ阻害効果(特開平9−124497号公報)、抗アレルギー効果(特開平10−53532号公報)などが知られている。
【0017】
しかしながら、キイチゴ属に属する植物及びキイチゴ抽出物が、皮膚の血行を促進するという報告はなく、これらを血行促進剤の有効成分として用いて、その皮膚の血行の促進作用により、若々しい肌を維持させようとする等の試みは、未だなされていない。本発明血行促進剤の有効成分として、上述したキイチゴ抽出物を配合することにより、例えば、皮膚外用剤として用いることで、皮膚の血行を促進し、使用者の健康と美容に貢献することが可能である。
【0018】
B.本発明血行促進剤の態様
本発明血行促進剤は、皮膚の血行を促進することから、基本的には外用剤、すなわち、皮膚外用剤としての態様を採り得る。
【0019】
本発明血行促進剤が、皮膚外用剤である場合には、キイチゴ抽出物は、乾燥重量として(以下、特に断らない限り同様である)、剤全量中0.0005〜20.0重量%配合するのが好ましく、より好ましくは同0.001〜10.0重量%である。この配合量が剤全量中0.0005重量%未満では、所望の血行促進効果が十分に発揮され難く、一方、同20.0重量%を超えると製剤化が困難になる。また、剤全量中10.0重量%を超えて配合しても、配合量の増加に見合った効果の大幅な向上は認められなくなる。
【0021】
本発明血行促進剤には、その態様や用途に応じて、必須配合成分であるキイチゴエキスの他に、必要により、本発明の効果を損なわない範囲内で、通常化粧品や医薬品等の皮膚外用剤に用いられる成分、例えば保湿剤、酸化防止剤、油分、紫外線防御剤、界面活性剤、増粘剤、アルコール類、粉末成分、色剤、金属イオン封鎖剤、防腐剤、水性成分、水、各種皮膚栄養剤等を必要に応じて適宜配合することができる。
【0022】
さらに、カフェイン、タンニン、ベラパミル、トラネキサム酸およびその誘導体、甘草抽出物、グラブリジン、カリンの果実の熱水抽出物、各種生薬、酢酸トコフェロール、グリチルリチン酸およびその誘導体またはその塩等の薬剤;ビタミンC、アスコルビン酸リン酸マグネシウム、アスコルビン酸グルコシド、アルブチン、コウジ酸等の美白剤;グルコース、フルクトース、マンノース、ショ糖、トレハロース等の糖類なども適宜配合することができる。
【0023】
本発明血行促進剤の剤型は、例えば、本発明血行促進剤が皮膚外用剤であれば、溶液系、可溶化系、乳化系、粉末分散系、水−油二層系、水−油−粉末三層系、ゲル、エアゾール等を選択することが可能である。
【0024】
なお、本発明血行促進剤が皮膚外用剤である場合の使用形態としては、例えば、化粧水、乳液、クリーム、パック等のフェーシャル化粧料やファンデーション、口紅、アイシャドウ等のメーキャップ化粧料、芳香化粧料、軟膏等に用いることができる。
【0025】
なお、上述した用途、剤型、使用形態は、それぞれ例示であって、これらの記述により、本発明血行促進剤の範囲が制限されるものではない。
【0026】
【実施例】
以下、実施例により、本発明を具体的に説明するが、これにより本発明の技術的範囲がなんら限定されるものでない。なお、配合量は、配合対象に対する重量%として表示する。
【0027】
実施例に先立ち、本発明のキイチゴ(Rubus idaeus Linne)溶媒抽出物の血行促進作用の試験方法について説明する。
〔参考例〕 試料の調製
ヨーロッパキイチゴ(R.idaeus L.) の果実1kgに、1,3−ブチレングリコールを加えて浸漬し、この浸漬液をろ過後、これと同量の精製水を加えて混合した後、さらにろ過し、ヨーロッパキイチゴの抽出液(以下、「本抽出液」と記す)15kgを得た。
【0028】
〔試験例〕 血行促進作用
本抽出液を、麻酔下のモルモットの皮膚に塗布し、塗布前と塗布30分後に、血流量をレーザードップラー血流計で測定した。対照として、50%の1,3−ブチレングリコールを塗布した。結果を第1表に示す。なお、血流増加率(%)は以下の式を用いて求めた。
【0029】
血流増加率(%)=(塗布30分後の血流量/塗布前の血流量)×100
【0030】

Figure 0003660833
【0031】
第1表に示したように、ヨーロッパキイチゴの乾燥残分濃度が1.7%の抽出液を用いることにより、対照に比べ有意に皮膚血流の増加が見られ、本抽出液の血行促進作用が確認された。
【0032】
以下に、種々の剤型の本発明血行促進剤の配合例を挙げる。なお、各実施例で用いたキイチゴ抽出物は常法により得たものを用い、その配合量は乾燥重量%で示す。これらの配合例の本発明血行促進剤について、それぞれの具体的な用途に応じた皮膚の血行の促進効果の検証を行った結果、いずれの例においても、皮膚の血行が促進していることが明らかになった。
【0033】
〔実施例1〕 クリーム
配合成分 配合量(重量%)
(1)ステアリン酸 5.0
(2)ステアリルアルコール 4.0
(3)イソプロピルミリステート 18.0
(4)グリセリンモノステアリン酸エステル 3.0
(5)プロピレングリコール 10.0
(6)キイチゴ抽出物 0.01
(7)苛性カリ 0.2
(8)亜硫酸水素ナトリウム 0.01
(9)防腐剤 適 量
(10)香料 適 量
(11)精製水 残 余
<製法>
(11)に(5)〜(7)を加え溶解し、加熱して70℃に保った(水相)。一方、(1)〜(4)、(8)〜(10)を混合して加熱溶融し、70℃に保った(油相)。次いで、水相に油相を攪拌しながら徐々に添加し、全部加え終わってからしばらくその温度に保ち反応を起こさせた。その後、ホモミキサーで均一に乳化し、よく攪拌しながら30℃まで冷却して、クリームを得た。
【0034】
〔実施例2〕 クリーム
Figure 0003660833
<製法>
(13)に(8)を加え溶解し、加熱して70℃に保った(水相)。一方、(1)〜(7)、(9)〜(12)を混合して加熱溶融し、70℃に保った(油相)。次いで、水相に油相を加え予備乳化を行い、ホモミキサーで均一に乳化した後、よく攪拌しながら30℃まで冷却して、クリームを得た。
【0035】
〔実施例3〕 乳液
Figure 0003660833
<製法>
少量の(13)に(8)を溶解した(A相)。残りの(13)に(6)〜(7)を加え、加熱溶解して70℃に保った(水相)。一方、(1)〜(5)、(9)〜(12)を混合し加熱溶融して70℃に保った(油相)。水相に油相を加え予備乳化を行い、さらにA相を加えホモミキサーで均一に乳化し、乳化後よく攪拌しながら30℃まで冷却して、乳液を得た。
【0036】
〔実施例4〕 乳液
Figure 0003660833
<製法>
(13)に(8)を加え、加熱して70℃に保った(水相)。一方、(1)〜(7)、(9)〜(12)を混合し、加熱溶融して70℃に保った(油相)。油相を攪拌しながら水相を徐々に加え、ホモミキサーで均一に乳化し、乳化後よく攪拌しながら30℃まで冷却して、乳液を得た。
【0037】
〔実施例5〕 ゼリー
Figure 0003660833
<製法>
(12)に(4)を均一に溶解した(水相)。一方、(1)に(7)と(3)を溶解し、これを水相に添加した。次いでここに、(2)、(8)〜(11)を加えた後、(5)、(6)で中和させ増粘して、ゼリーを得た。
【0038】
〔実施例6〕 美容液
配合成分 配合量(重量%)
(A相)
95%エチルアルコール 10.0
ポリオキシエチレン(20モル)オクチルドデカノール 1.0
パントテニルエチルエーテル 0.1
キイチゴ抽出物 1.5
メチルパラベン 0.15
(B相)
水酸化カリウム 0.1
(C相)
グリセリン 5.0
ジプロピレリングリコール 10.0
亜硫酸水素ナトリウム 0.03
カルボキシビニルポリマー 0.2
(「カーボポール941」;B.F.Goodrich Chemical Company )
精製水 残 余
<製法>
A相、C相をそれぞれ均一に溶解し、C相にA相を加えて可溶化した。次いでB相を加え充填を行い、美容液を得た。
【0039】
〔実施例7〕 パック
配合成分 配合量(重量%)
(A相)
ジプロピレングリコール 5.0
ポリオキシエチレン(60モル)硬化ヒマシ油 5.0
(B相)
キイチゴ抽出物 0.01
オリーブ油 5.0
酢酸トコフェロール 0.2
エチルパラベン 0.2
香料 0.2
(C相)
亜硫酸水素ナトリウム 0.03
ポリビニルアルコール(ケン化度90、重合度2000) 13.0
エタノール 7.0
精製水 残 余
<製法>
A相、B相、C相をそれぞれ均一に溶解し、A相にB相を加えて可溶化した。次いでC相を加え充填を行い、パックを得た。
【0040】
〔実施例8〕 固形ファンデーション
配合成分 配合量(重量%)
(1)タルク 42.8
(2)カオリン 15.0
(3)セリサイト 10.0
(4)亜鉛華 7.0
(5)二酸化チタン 3.8
(6)黄色酸化鉄 2.9
(7)黒色酸化鉄 0.2
(8)スクワラン 8.0
(9)イソステアリン酸 4.0
(10)モノオレイン酸POEソルビタン 3.0
(11)オクタン酸イソセチル 2.0
(12)キイチゴ抽出物 1.0
(13)防腐剤 適 量
(14)香料 適 量
<製法>
(1)〜(7)の粉末成分をブレンダーで十分混合し、これに(8)〜(11)の油性成分、(12)、(13)、(14)を加え、よく混練した後、容器に充填、成型して、固形ファンデーションを得た。
【0041】
〔実施例9〕 乳化ファンデーション(クリームタイプ)
配合成分 配合量(重量%)
(粉体部)
二酸化チタン 10.3
セリタイト 5.4
カオリン 3.0
黄色酸化鉄 0.8
ベンガラ 0.3
黒色酸化鉄 0.2
(油相)
デカメチルシクロペンタシロキサン 11.5
流動パラフィン 4.5
ポリオキシエチレン変性ジメチルポリシロキサン 4.0
(水相)
精製水 50.0
1,3−ブチレングリコール 4.5
キイチゴ抽出物 1.5
防腐剤 適 量
香料 適 量
<製法>
水相を加熱攪拌後、十分に混合粉砕した粉体部を添加してホモミキサー処理した。さらに加熱混合した油相を加えてホモミキサー処理した後、攪拌しながら香料を添加して室温まで冷却して、乳化ファンデーションを得た。
【0042】
〔実施例10〕 クリーム
Figure 0003660833
<製法>
(13)に(8)を加え溶解し、加熱して70℃に保った(水相)。一方、(1)〜(7)、(9)〜(12)を混合して加熱溶解し、70℃に保った(油相)。次いで、水相に油相を加え予備乳化を行い、ホモミキサーで均一に乳化した後、よく攪拌しながら30℃まで冷却して、クリームを得た。
【0044】
【発明の効果】
本発明により、皮膚の血行を促進することにより、使用者の健康と美容に貢献し得る血行促進剤が提供される。[0001]
BACKGROUND OF THE INVENTION
The present invention is an invention relating to a blood circulation promoter having an action of promoting skin blood circulation, comprising a plant extract as an active ingredient.
[0002]
[Prior art]
Promoting skin circulation is very beneficial for physical health and beauty. That is, by promoting blood circulation in the skin, metabolism of the body is promoted, which is very beneficial for the whole body. Also, cosmetically, it is possible to improve skin color and prevent dull skin, and it is moistened by sufficient supply of nutrients and moisture to the skin tissue by improving metabolism in the skin It also makes it possible to maintain youthful skin, which can prevent skin aging, and its benefits are immeasurable.
[0003]
Therefore, attempts have been made to find a component that can promote blood circulation of the skin, and to use this as an active ingredient of a blood circulation promoter that can be used as a skin external preparation or bath preparation. Examples of components that have been found so far that can promote blood circulation of the skin include capsaicin, vitamin E, mugwort extract and the like.
[0004]
[Problems to be solved by the invention]
The problem to be solved by the present invention is to further find a blood circulation promoting component suitable for external use, thereby providing a new means that can promote blood circulation of the skin and contribute to physical health and beauty.
[0005]
[Means for Solving the Problems]
As a result of intensive studies, the present inventor has found that an extract of a plant belonging to the genus Rubus L. belonging to the family Rosaceae has an excellent effect of promoting blood circulation of the skin, and this is used as a blood circulation promoter. It discovered that said subject could be solved by using as an active ingredient.
[0006]
That is, the present inventor, in the present application, a blood circulation promoter (hereinafter referred to as raspberry extract) of a plant belonging to the genus Rosaceae (RubusL.) Hereinafter, the blood circulation promoter of the present invention is also provided. By using this blood circulation promoter of the present invention as, for example, a skin external preparation , its characteristics can be fully exhibited.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
Embodiments of the present invention will be described below.
A. The active ingredient of the blood circulation promoter of the present invention The plant belonging to the genus Rubus L., which is a raw material of the extract of raspberry which is the active ingredient of the blood circulation promoter of the present invention, is as follows. Rosaceae), commonly known as Blackberry or Raspberry, and its fruits are widely used for food.
[0008]
In the present invention, the plant belonging to the genus Rubus is not particularly limited, and one or more kinds can be freely selected from existing species of the genus Rubus and various hybrids.
[0009]
As existing species of plants belonging to the genus Rubus, Rubus (hereinafter also referred to as R.) allegheniensis Port., Chishima strawberry (R. arcticus L.), R. argutus Link, Fuyu strawberry (R. buergeri Miq.), R. caesius L., R. canadensis L., Holomui strawberry (R. chamaemorus L.), Gosho strawberry (R. chingii Hu), R. commersonii, Bear strawberry (R. crataegifolious Bunge), Oni strawberry (R. ellipticus Sm.), R. frondosus Bigel., R.fruticosus L., R.hayata-koidzumii Naruhashi, R.hirsutus Thunb., European raspberry (R.idaeus L.), Rose strawberry (R) .illecebrosus Focke), R.laciniatus Willd., R. × loganobaccus Bailey, green strawberry (R.microphyllus Lf), Chinese strawberry (R.moluccanus L.), R. × neglectus Peck., R.niveus Thunb. (R.occidentalis L.), Momiji strawberry (R.palmatus Thunb.), Nawashiro strawberry (R.parvifolius L.), Koga Strawberry (R. pedatus JESmith), Shrimp strawberry (R. phoenicolasius), R. proceus PJMuell. Examples include, but are not limited to, spectabilis Pursh., red strawberry (R. trifidus Thunb.), R. ursinus Cham. et Schlecht., safflower strawberry (R. vernus Focke).
[0010]
Among these plants belonging to the genus Rubus, European raspberry (R. idaeus L.), its subspecies (for example, subsp.vulgatus, subsp.strigosus, subsp.melanolasia Focke, subsp.sachalinensis Leveille, subsp.sibiricus, etc.) ) And related species (for example, Horomui strawberry, R. xanthocarpus, Chishima strawberry, Nawashiro strawberry, Kuromiki strawberry, R. ursinus, Momiji strawberry, etc.) can be preferably used in the present invention. In the present invention, “European raspberry” includes the above-mentioned subspecies and related species.
[0011]
Plants belonging to the genus Rhizobe that can be a raw material for raspberry extract can be used either raw or dried, and the site of use widely uses the whole plant body, that is, flowers, leaves, stems or fruits. However, it is particularly preferable to select fruits.
[0012]
The raspberry extract can be used as a fruit juice derived from the fruit or the like, or is subjected to an extraction step (for example, after being immersed or heated to reflux with an extraction solvent and then filtered and concentrated) from the plant belonging to the genus Raspberry. It is also possible to use an extract obtained by a conventional method. . In addition, an extract obtained by extraction with an extraction solvent as it is or after concentration is obtained by treating the extract with an adsorption method [for example, a product obtained by removing impurities using an ion exchange resin, a porous polymer ( For example, it is adsorbed on a column of Amberlite XAD-2), eluted with methanol or ethanol, concentrated, etc.], or a partition method, for example, an extract extracted with water / ethyl acetate, etc. Can do. As said extraction solvent, if it is a solvent normally used for extraction, it can be used arbitrarily, for example, water, alcohols (methanol, ethanol, propylene glycol, 1, 3- butylene glycol, glycerol, etc.), Hydrous alcohols, chloroform, dichloroethane, carbon tetrachloride, acetone, ethyl acetate, hexane and the like can be used alone or in combination.
[0013]
In addition, commercially available products of raspberry extract can also be used in the present invention [for example, “raspberry extract BG” (manufactured by Maruzen Co., Ltd.), “dermofruit raspberry” (manufactured by Koei Kogyo Co., Ltd.) as raspberry extract. Furthermore, “Dermo Fruit Raspberry B” (manufactured by Koei Kogyo Co., Ltd.) etc. as raspberry juice.
[0014]
The raspberry extract in the present invention includes, in addition to literal extracts as described above, raw or dried plants of plants belonging to the genus Raspberry.
[0015]
Plants belonging to the genus Rubus contain various vitamins and saccharides, mainly malic acid, citric acid, flavonoids, vitamin C and vitamin P, as their medicinal ingredients, so dermatitis (eczema, acne), anti-inflammatory agent It is known to be used to prevent diarrhea.
[0016]
The raspberry extract contains hair growth, hair growth effect (Japanese Patent Laid-Open No. 3-188014), acne improvement effect (Japanese Patent Laid-Open No. 3-188015), melanin production inhibitory effect (Japanese Patent Laid-Open No. 7-25741), Hyaluronidase inhibitory effect (Japanese Patent Laid-Open No. 9-124497), antiallergic effect (Japanese Patent Laid-Open No. 10-53532), and the like are known.
[0017]
However, there is no report that plants belonging to the genus Rubus and raspberry extract promote the blood circulation of the skin, and these are used as an active ingredient of the blood circulation promoting agent, and the blood circulation promoting action of the skin results in youthful skin. No attempt has been made to maintain it. By blending the above-mentioned raspberry extract as an active ingredient of the blood circulation promoter of the present invention, for example, it can be used as a skin external preparation to promote blood circulation of the skin and contribute to the health and beauty of the user. It is.
[0018]
B. Embodiments of the present blood circulation promoter The present blood circulation promoter promotes the blood circulation of the skin, and therefore can be basically applied as an external preparation, that is, an external skin preparation .
[0019]
When the blood circulation promoter of the present invention is a skin external preparation, the raspberry extract is blended in a dry weight (hereinafter, the same unless otherwise specified), and 0.0005 to 20.0% by weight in the total amount of the agent. Is more preferable, and 0.001 to 10.0% by weight is more preferable. If the blending amount is less than 0.0005% by weight in the total amount of the agent, the desired blood circulation promoting effect is hardly exerted, whereas if it exceeds 20.0% by weight, it becomes difficult to make a preparation. Moreover, even if it mixes exceeding 10.0 weight% in an agent whole quantity, the significant improvement of the effect corresponding to the increase in a compounding quantity will not be recognized.
[0021]
In the blood circulation promoter of the present invention, in addition to raspberry extract, which is an essential component, depending on the mode and application, skin external preparations such as cosmetics and pharmaceuticals are usually used as long as the effects of the present invention are not impaired. components used in, for example, humectants, antioxidants, oil, UV protecting agents, surfactants, thickeners, alcohols, powder components, coloring agent, sequestering agents, preservatives, aqueous components, water, various A skin nutrient or the like can be appropriately blended as necessary.
[0022]
Furthermore, drugs such as caffeine, tannin, verapamil, tranexamic acid and derivatives thereof, licorice extract, grabrizine, hot water extract of carin fruit, various herbal medicines, tocopherol acetate, glycyrrhizic acid and derivatives thereof or salts thereof; vitamin C , Whitening agents such as magnesium ascorbate phosphate, glucoside ascorbate, arbutin and kojic acid; sugars such as glucose, fructose, mannose, sucrose, trehalose and the like can be appropriately blended.
[0023]
The dosage form of the present blood circulation promoter is, for example, a solution system, a solubilization system, an emulsification system, a powder dispersion system, a water-oil two-layer system, a water-oil- if the blood circulation promoter of the present invention is an external preparation for skin. It is possible to select a powder three-layer system, gel, aerosol or the like.
[0024]
The use form when the blood circulation promoter of the present invention is an external preparation for skin includes, for example, facial cosmetics such as lotions, emulsions, creams and packs, makeup cosmetics such as foundations, lipsticks and eye shadows, and aromatic makeup. It can be used for preparations, ointments, etc.
[0025]
In addition, the use mentioned above, dosage form, and usage form are illustrations, respectively, and the scope of the blood circulation promoter of the present invention is not limited by these descriptions.
[0026]
【Example】
Hereinafter, the present invention will be specifically described by way of examples. However, the technical scope of the present invention is not limited to the examples. In addition, a compounding quantity is displayed as weight% with respect to a mixing object.
[0027]
Prior to the examples, the method for testing the blood circulation promoting effect of the solvent extract of Rubus idaeus Linne according to the present invention will be described.
[Reference Example] Preparation of sample 1 kg of European raspberry (R. idaeus L.) fruit is dipped in 1,3-butylene glycol, filtered, and then the same amount of purified water is added. After mixing, the mixture was further filtered to obtain 15 kg of European raspberry extract (hereinafter referred to as “this extract”).
[0028]
[Test Example] Blood circulation promoting action This extract was applied to the skin of anesthetized guinea pigs, and the blood flow was measured with a laser Doppler blood flow meter before and 30 minutes after application. As a control, 50% 1,3-butylene glycol was applied. The results are shown in Table 1. In addition, the blood flow increase rate (%) was calculated | required using the following formula | equation.
[0029]
Blood flow increase rate (%) = (blood flow volume 30 minutes after application / blood flow volume before application) × 100
[0030]
Figure 0003660833
[0031]
As shown in Table 1, the use of an extract with a dry residue concentration of 1.7% of European raspberry significantly increased skin blood flow compared to the control. Was confirmed.
[0032]
Below, the formulation example of this invention blood circulation promoter of various dosage forms is given. In addition, the raspberry extract used in each Example uses what was obtained by the conventional method, The compounding quantity is shown by dry weight%. Regarding the blood circulation promoters of the present invention of these formulation examples, as a result of verifying the effect of promoting skin blood circulation in accordance with each specific use, in all cases, the blood circulation of the skin is promoted. It was revealed.
[0033]
[Example 1] Cream
Compounding ingredients blending amount (wt%)
(1) Stearic acid 5.0
(2) Stearyl alcohol 4.0
(3) Isopropyl myristate 18.0
(4) Glycerol monostearate 3.0
(5) Propylene glycol 10.0
(6) Raspberry extract 0.01
(7) Caustic potash 0.2
(8) Sodium bisulfite 0.01
(9) Preservative appropriate amount (10) Fragrance appropriate amount (11) Purified water residue <Production method>
(5) to (7) were added to (11), dissolved, and heated to maintain at 70 ° C. (aqueous phase). On the other hand, (1) to (4) and (8) to (10) were mixed, heated and melted, and kept at 70 ° C. (oil phase). Subsequently, the oil phase was gradually added to the aqueous phase with stirring, and after the addition was completed, the temperature was maintained for a while to cause a reaction. Thereafter, the mixture was uniformly emulsified with a homomixer and cooled to 30 ° C. with good stirring to obtain a cream.
[0034]
[Example 2] Cream
Figure 0003660833
<Production method>
(8) was added to (13) and dissolved, and heated to 70 ° C. (water phase). On the other hand, (1) to (7) and (9) to (12) were mixed, heated and melted, and kept at 70 ° C. (oil phase). Next, the oil phase was added to the aqueous phase, preliminarily emulsified, and uniformly emulsified with a homomixer, and then cooled to 30 ° C. with good stirring to obtain a cream.
[0035]
[Example 3] Emulsion
Figure 0003660833
<Production method>
(8) was dissolved in a small amount of (13) (A phase). (6) to (7) were added to the remaining (13), dissolved by heating and kept at 70 ° C. (aqueous phase). On the other hand, (1) to (5) and (9) to (12) were mixed, heated and melted, and kept at 70 ° C. (oil phase). The oil phase was added to the aqueous phase for preliminary emulsification, and the A phase was further added, and the mixture was uniformly emulsified with a homomixer.
[0036]
[Example 4] Emulsion
Figure 0003660833
<Production method>
(8) was added to (13) and heated to 70 ° C. (aqueous phase). On the other hand, (1) to (7) and (9) to (12) were mixed, melted by heating and kept at 70 ° C. (oil phase). The aqueous phase was gradually added while stirring the oil phase, and the mixture was uniformly emulsified with a homomixer. After emulsification, the emulsion was cooled to 30 ° C. with good stirring to obtain an emulsion.
[0037]
[Example 5] Jelly
Figure 0003660833
<Production method>
(4) was uniformly dissolved in (12) (aqueous phase). On the other hand, (7) and (3) were dissolved in (1) and added to the aqueous phase. Next, after adding (2) and (8) to (11), the mixture was neutralized and thickened with (5) and (6) to obtain a jelly.
[0038]
[Example 6] Cosmetic liquid
Compounding ingredients blending amount (wt%)
(Phase A)
95% ethyl alcohol 10.0
Polyoxyethylene (20 mol) octyldodecanol 1.0
Pantothenyl ethyl ether 0.1
Raspberry extract 1.5
Methylparaben 0.15
(Phase B)
Potassium hydroxide 0.1
(Phase C)
Glycerin 5.0
Dipropylene glycol 10.0
Sodium bisulfite 0.03
Carboxyvinyl polymer 0.2
(“Carbopol 941”; BFGoodrich Chemical Company)
Purified water residue <Production method>
The A phase and the C phase were uniformly dissolved, and the A phase was added to the C phase and solubilized. Next, Phase B was added and filled to obtain a cosmetic liquid.
[0039]
[Example 7] Pack
Compounding ingredients blending amount (wt%)
(Phase A)
Dipropylene glycol 5.0
Polyoxyethylene (60 mol) hydrogenated castor oil 5.0
(Phase B)
Raspberry extract 0.01
Olive oil 5.0
Tocopherol acetate 0.2
Ethylparaben 0.2
Fragrance 0.2
(Phase C)
Sodium bisulfite 0.03
Polyvinyl alcohol (degree of saponification 90, degree of polymerization 2000) 13.0
Ethanol 7.0
Purified water residue <Production method>
A phase, B phase, and C phase were uniformly dissolved, and B phase was added to A phase to solubilize. Next, Phase C was added and filled to obtain a pack.
[0040]
[Example 8] Solid foundation
Compounding ingredients blending amount (wt%)
(1) Talc 42.8
(2) Kaolin 15.0
(3) Sericite 10.0
(4) Zinc flower 7.0
(5) Titanium dioxide 3.8
(6) Yellow iron oxide 2.9
(7) Black iron oxide 0.2
(8) Squalane 8.0
(9) Isostearic acid 4.0
(10) POE sorbitan monooleate 3.0
(11) Isocetyl octanoate 2.0
(12) Raspberry extract 1.0
(13) Preservative appropriate amount (14) Fragrance appropriate amount <Production method>
The powder components (1) to (7) are sufficiently mixed with a blender, and the oily components (8) to (11), (12), (13), and (14) are added to this and kneaded well. Filled and molded into a solid foundation.
[0041]
[Example 9] Emulsification foundation (cream type)
Compounding ingredients blending amount (wt%)
(Powder part)
Titanium dioxide 10.3
Celiteite 5.4
Kaolin 3.0
Yellow iron oxide 0.8
Bengala 0.3
Black iron oxide 0.2
(Oil phase)
Decamethylcyclopentasiloxane 11.5
Liquid paraffin 4.5
Polyoxyethylene-modified dimethylpolysiloxane 4.0
(Water phase)
Purified water 50.0
1,3-butylene glycol 4.5
Raspberry extract 1.5
Preservative Appropriate amount Fragrance Appropriate amount <Production method>
After the aqueous phase was heated and stirred, the powder part sufficiently mixed and ground was added and homomixed. Furthermore, after adding the heat-mixed oil phase and carrying out a homomixer process, the fragrance | flavor was added, stirring, and it cooled to room temperature, and obtained the emulsion foundation.
[0042]
[Example 10] Cream
Figure 0003660833
<Production method>
(8) was added to (13) and dissolved, and heated to 70 ° C. (water phase). On the other hand, (1) to (7) and (9) to (12) were mixed, dissolved by heating, and kept at 70 ° C. (oil phase). Next, the oil phase was added to the aqueous phase, preliminarily emulsified, and uniformly emulsified with a homomixer, and then cooled to 30 ° C. with good stirring to obtain a cream.
[0044]
【The invention's effect】
The present invention provides a blood circulation promoter that can contribute to the health and beauty of a user by promoting blood circulation of the skin.

Claims (4)

バラ科キイチゴ属(Rubus L.)に属する植物の抽出物を有効成分とする血行促進剤(当該血行促進剤が浴用剤である場合を除く)A blood circulation promoter comprising an extract of a plant belonging to the genus Rubus L. ( except when the blood circulation promoter is a bath agent) . バラ科キイチゴ属に属する植物が、ヨーロッパキイチゴである、請求項1記載の血行促進剤。The blood circulation promoter according to claim 1, wherein the plant belonging to the genus Rosaceae is European raspberry. バラ科キイチゴ属(Rubus L.)に属する植物の抽出物が、その花、葉、茎及び果実からなる群から選ばれる部位の1種若しくは2種以上に由来する抽出物である、請求項1又は2記載の血行促進剤。2. The plant extract belonging to the genus Rubus L. is an extract derived from one or more of sites selected from the group consisting of flowers, leaves, stems and fruits. Or the blood circulation promoter of 2. 血行促進剤が、皮膚外用剤である、請求項1ないし3のいずれかの請求項記載の血行促進剤。The blood circulation promoter according to any one of claims 1 to 3, wherein the blood circulation promoter is a skin external preparation.
JP22232299A 1999-08-05 1999-08-05 Blood circulation promoter Expired - Fee Related JP3660833B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22232299A JP3660833B2 (en) 1999-08-05 1999-08-05 Blood circulation promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22232299A JP3660833B2 (en) 1999-08-05 1999-08-05 Blood circulation promoter

Publications (2)

Publication Number Publication Date
JP2001048740A JP2001048740A (en) 2001-02-20
JP3660833B2 true JP3660833B2 (en) 2005-06-15

Family

ID=16780548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22232299A Expired - Fee Related JP3660833B2 (en) 1999-08-05 1999-08-05 Blood circulation promoter

Country Status (1)

Country Link
JP (1) JP3660833B2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4889069B2 (en) * 2001-04-24 2012-02-29 丸善製薬株式会社 Moisturizer, whitening agent and skin cosmetics
JP4587647B2 (en) * 2003-05-06 2010-11-24 丸善製薬株式会社 Fibroblast growth promoter, skin cosmetics and cosmetics
JP2006290749A (en) * 2005-04-06 2006-10-26 Ichimaru Pharcos Co Ltd Melanogenesis inhibitor
JP2008081441A (en) * 2006-09-27 2008-04-10 Noevir Co Ltd Protease activity promoter
CN102905686B (en) * 2010-05-31 2016-02-10 株式会社资生堂 Skin temperature elevating agents and the cosmetics containing this skin temperature elevating agents, food and groceries
JP5975585B2 (en) * 2011-09-27 2016-08-23 農事組合法人ホワイトベリー Hair preparation
KR101191140B1 (en) 2012-03-28 2012-10-15 태경환 Cosmetic composition comprising the fruit extract of rubus hirsutus thunb. and horse fat for skin care

Also Published As

Publication number Publication date
JP2001048740A (en) 2001-02-20

Similar Documents

Publication Publication Date Title
JP3711377B2 (en) Emulsifier, emulsified cosmetic and production method thereof
KR102142311B1 (en) Skin external composition comprising tangeretin
KR20130088912A (en) Skin external composition containing tangeretin and egcg
JP2001163794A (en) Promoter for production of hyaluronic acid and preparation for external use for skin
JPH06199646A (en) Skin beautifying cosmetic
JPH0566922B2 (en)
JP2004067590A (en) Female sex hormone production promoter and skin preparation for external use containing the same
JP3660833B2 (en) Blood circulation promoter
JP2001158728A (en) Agent for promoting production of hyaluronic acid and skin preparation for external use
KR101419588B1 (en) Composition for Moisturizing Skin Comprising Ginseng Oil as Active Ingredient
JP2009067718A (en) Skin preparation for external use containing phenolic compound in sap of plant of aceraceae
JP2003160461A (en) Skin care preparation
JPH0812560A (en) Skin external preparation
JP4500906B2 (en) Cosmetic compounding agent and cosmetics containing the same
JP2000096050A (en) Promoter for production of hyaluronic acid
JP3987733B2 (en) Fibroblast activator and skin external preparation containing the same
JPH0812561A (en) Beautifying and whitening skin preparation for external use
JP2009209063A (en) Skin preparation for external use, or skin cosmetic
KR20090126992A (en) Cosmetic application of defatted camellia japonica seed debris and seed coats and its extract
CN106265211B (en) Cistanche salsa supernatant mixture, preparation method thereof and skin barrier repair effect thereof
JP2000226311A (en) Anti-aging agent
KR20070008831A (en) Cosmetic composition comprising olive extract, oat extract and honey having skin refreshing effect
JP2000159626A (en) Preparation for external use for skin
JP2000119133A (en) Skin lotion for bleaching
JPH11335230A (en) Skin lotion

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20041125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041207

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050201

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20050318

R150 Certificate of patent or registration of utility model

Ref document number: 3660833

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090325

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090325

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100325

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110325

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120325

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120325

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130325

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140325

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees